Pharmacologic modulation of PAF-induced mortality in mice
- 22 Downloads
- 7 Citations
Abstract
The effect of antiinflammatory drugs, phosphodiesterase inhibitors, leukotriene and mediator antagonists and other drug classes were evaluated in a PAF-induced mortality model in mice. By the oral route of administration (−1 hr), dapsone (ED50=25 mg/kg), BW 755C (ED50=29 mg/kg), theophylline (ED50=30 mg/kg) and LY-171,883 (ED50=50 mg/kg) protected against PAF-induced lethality in the mouse. Other drugs that afforded protection when given at various dosing schedules and routes were NDGA (100 mg/kg, −18 hr p.o.), diphenyldisulfide (200 mg/kg, −18 hr p.o.), dexamethasone (1 mg/kg, −3 hr p.o.), dipyridamole (2 mg/kg, −2 min i.v.) and kadsurenone (10 mg/kg, −2 min i.v.). Nonsteroidal antiinflammatory drugs (NSAIDs) such as indomethacin were inactive and the combination of AA-861, a putative 5-LO inhibitor, and indomethacin also failed to prevent PAF-induced lethality. Therefore, our pharmacological data do not consistently support the notion that PAF-induced lethality is due unequivocally to leukotrienes derived from 5-lipoxygenase metabolism.
Keywords
Dexamethasone Indomethacin Theophylline Antiinflammatory Drug DipyridamolePreview
Unable to display preview. Download preview PDF.
References
- [1]J. M. Young, P. J. Maloney, S. N. Jubb and J. S. Clark,Pharmacologic investigation of the mechanisms of platelet activating factor induced mortality in the mouse. Prostaglandins30, 545–551 (1985).CrossRefPubMedGoogle Scholar
- [2]T. Yoshimoto, C. Yokoyama, K. Ochi, S. Yamamoto, Y. Maki, Y. Ashida, S. Terao and M. Shiraishi,2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861) A selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim. Biophys. Acta713, 430–473 (1982).Google Scholar
- [3]S. M. Coutts, A. Khandwala, R. Van Inwegen, U. Chakraborty, J. Musser, J. Bruens, N. Jariwala, V. Dally-Meade, R. Ingram, T. Pruss, H. Jones, E. Neiss and I. Weinryb,Arylmethylphenyl ethers — A new class of specific inhibitors of 5-lipoxygenase. InProstaglandins, leukotrienes and lipoxins (Ed. J. M. Bailey). Plenum Press, New York 1985.Google Scholar
- [4]D. Kelefiotis and C. Vakirtzi-Lemonias,Effect of non-steroidal antiinflammatory drugs on alkyl-acetyl-glycerol-phosphorylcholine-induced anaphylactic shock in mice. Biochem. Soc. Transactions14, 94–95 (1986).Google Scholar
- [5]Y. Ashida, T. Saijo, H. Kuriki, H. Makino, S. Terao and Y. Maki,Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor. Prostglandins26, 955–972 (1983).CrossRefGoogle Scholar
- [6]R. J. Gordon, J. Travis, H. R. Godfrey, D. Sweeney, P. S. Wolf, T. P. Pruss, E. Neiss, J. Musser, U. Chakraborty, H. Jones and M. Leibowitz,In vivo activity of a lipoxygenase inhibitor and leukotriene antagonist, REV 5901-A. Leukotrienes Prostaglandins84, 266 (1984).Google Scholar
- [7]J. C. Foreman,The pharmacological control of immediate hypersensitivity. Ann. Rev. Pharmacol. Toxicol.21, 63–81 (1981).CrossRefGoogle Scholar